Toronto Stock Exchange Symbol: SXC
Systems Xcellence announces record 2006 fIRST quarter financial results- Revenue and EBITDA increase organically 83% and 343%, respectively -MILTON, Ontario May 4, 2006, Systems Xcellence Inc., (“SXC” or the “Company”) (TSX: SXC) a leading provider of healthcare information technology solutions throughout the pharmaceutical supply chain, announces financial results for the three-month period ended March 31, 2006. All figures are in U.S. dollars, unless otherwise noted. Highlights for Q1:
“We are extremely pleased with our start to the new year,” said Gordon S. Glenn President and CEO of SXC. “Q1 results exceeded our expectations due primarily to increased transaction processing revenue generated from both the Medicare Part D program and new customers that began processing on January 1, 2006. To a lesser extent, significant professional service and software license revenue from clients that are participating in the Part D program also contributed to this growth. So far, both the number of lives and the volume of transactions processed relative to Part D have surpassed our initial targets. We believe the contribution of revenue related to Part D will normalize somewhat throughout the remainder of the year, however, due to our strong start, we are revising our guidance upward.” Financial Review Revenue for the three-month period ended March 31, 2006 was $19.3 million, up 83% compared to $10.6 million in the same period last year. Revenue of a recurring nature was $12.4 million during this period, up 52% compared to $8.2 million in the first quarter of 2005. Transaction processing revenue was $8.8 million in the first quarter, up 77% compared to $5.0 million in the same period of 2005. Revenue from non-recurring sources was $6.9 million in Q1 compared to $2.4 million in the prior period, a 187.5% increase. Systems sales revenue (which includes both software and hardware license revenue) was $2.55 million in the current period, compared to $1.1 million in the prior period, a 132% increase. Professional service revenue was $4.4 million compared to $1.3 million in the prior period, a 238% increase. First quarter revenue growth was driven primarily to the increase in transaction processing volume along with consulting and implementation services performed for customers who are participating in the Part D program. Gross margin for the first quarter was 61%, compared with 57% in the same period last year. The increase in gross margin is primarily due to the increase in higher margin transaction processing revenue and professional services revenue related to the launch of Part D. Product development expenses on an absolute dollar basis were consistent at $2.1 million, or 11% of revenue, compared with $2.1 million, or 20% in the same period last year. Product development expenses decreased as a percentage of revenue due primarily to personnel resources being temporarily allocated to Part D professional services projects in Q1 2006. SG&A expenses were $3.9 million, or 20% of revenue, compared with $2.6 million, or 24% of revenue in the same period last year. SG&A expenses rose on an absolute dollar basis as the Company invested in its sales capabilities and in bringing new products to market. First quarter EBITDA was $5.8 million, or 30% of revenue, compared to $1.3 million, or 12% of revenue. The increase in EBITDA reflects the significant increase in revenue, an increase in higher margin transaction processing revenue and SXC’s ongoing efforts at cost control. Net income for the first quarter was $5.6 million, or $0.08 per share (fully diluted) compared with $15,606, or $0.00 per share, in the first quarter last year. Net income includes a $0.8 million lease termination charge for its facility in Illinois as the Company has entered into a lease for a new location. The new landlord has provided an offsetting $0.8 million lease inducement; however this inducement will be amortized over the term of the new lease. In addition net income includes a non-cash $1.9 million future tax recovery that was recognized based on the expected future profitability of SXC coupled with its tax loss carry forwards. Liquidity and Resources SXC continues to operate with a strong balance sheet from which to pursue its growth initiatives. At March 31, 2006, the company had a working capital position of $41.0 million, with cash and cash-equivalents of $36.9 million, compared with $37.3 million of working capital and $36 million of cash and cash-equivalents at March 31, 2005. In the first quarter of 2006, SXC generated cash from operations of $1.8 million, an increase of 148% compared to $0.7 million generated in the first quarter last year. 2006 Financial Guidance As a result of the strong start to 2006, the Company has revised its guidance upward and has established the following financial goals for fiscal 2006: consolidated revenue of $70-73 million, EBITDA of $17.5-19 million and earnings per share (fully-diluted) of $0.16-0.18. In addition, for 2006, the Company expects to increase overall transaction processing levels by at least 96% to more than 275 million adjudicated and switched transactions. Approximately 41% of this growth, or 55 million transactions, is expected to result from the Part D program with the balance originating from the Company’s commercial and State Medicaid initiatives. EBITDA Reconciliation to Net Income EBITDA (earnings before interest, taxes, depreciation and amortization) is a non-GAAP measure that management believes is a useful supplemental measure of operating performance prior to amortization, debt service and income tax. Investors are cautioned that EBITDA should not be construed as an alternative to net income determined in accordance with GAAP as an indicator of the Company's performance or to cash flows from operations as a measure of liquidity and cash flows. EBITDA does not have a standardized meaning prescribed by GAAP. The Company's method of calculating EBITDA may differ from the methods used by other companies and, accordingly, it may not be comparable to similarly titled measures used by other companies. Reconciliation of EBITDA to net income is shown below:
Notice of Conference Call SXC will host a conference call on May 4, 2006 at 8:30AM (ET) to discuss its first quarter financial results. Mr. Gordon S. Glenn, President and CEO, will host the call. To participate on the call, please dial 416-644-3429 or 1-800-814-4857. A replay of the call can be heard by dialling 1-877-289-8525 or 416-640-1917 and entering the reference code 21185972. The taped call is available until May 11, 2006. A live audio webcast of the call will be available at www.sxc.com and www.newswire.ca. Webcast attendees are welcome to listen to the conference in real-time or on-demand at your convenience. About Systems Xcellence Inc. Systems Xcellence (SXC) is headquartered in Milton, Ontario with offices and processing centres in Lombard, Illinois, Warminster, Pennsylvania, Scottsdale, Arizona and Victoria, British Columbia. Through its subsidiary, SXC Health Solutions, Inc., SXC is a leading provider of healthcare information technology solutions and services to the U.S. healthcare benefits management industry. The company’s product offerings and solutions combine a wide range of software applications, application service provider (ASP) processing services and professional services, designed for many of the largest organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, independent, chain and mail-order pharmacies and other healthcare intermediaries. SXC can be found on the Internet at www.sxc.com. This press release contains forward-looking statements based on current expectations. These forward-looking statements entail various risks and uncertainties that could cause actual results to differ materially from those reflected in these forward-looking statements. Risks and uncertainties about the Company's business are more fully discussed in the Company's Annual Information Form.
For more information, please contact:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||